Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1163053.RAQw6eCkcym3-fVT_5mIryZC-ixjoBP79dQZToH1Fsc9w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1163053.RAQw6eCkcym3-fVT_5mIryZC-ixjoBP79dQZToH1Fsc9w130_assertion type Assertion NP1163053.RAQw6eCkcym3-fVT_5mIryZC-ixjoBP79dQZToH1Fsc9w130_head.
- NP1163053.RAQw6eCkcym3-fVT_5mIryZC-ixjoBP79dQZToH1Fsc9w130_assertion description "[In our prospective study, hyper-variable regions (CDRI and III) of IgH, TCRD (V?2-D?3 and D?2-D?3), TCRG (V?, V?I, and V?II), and IgK (V?-Kde) were studied in 126 cases with diagnosis of B-precursor ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1163053.RAQw6eCkcym3-fVT_5mIryZC-ixjoBP79dQZToH1Fsc9w130_provenance.
- NP1163053.RAQw6eCkcym3-fVT_5mIryZC-ixjoBP79dQZToH1Fsc9w130_assertion evidence source_evidence_literature NP1163053.RAQw6eCkcym3-fVT_5mIryZC-ixjoBP79dQZToH1Fsc9w130_provenance.
- NP1163053.RAQw6eCkcym3-fVT_5mIryZC-ixjoBP79dQZToH1Fsc9w130_assertion SIO_000772 24620952 NP1163053.RAQw6eCkcym3-fVT_5mIryZC-ixjoBP79dQZToH1Fsc9w130_provenance.
- NP1163053.RAQw6eCkcym3-fVT_5mIryZC-ixjoBP79dQZToH1Fsc9w130_assertion wasDerivedFrom befree-2016 NP1163053.RAQw6eCkcym3-fVT_5mIryZC-ixjoBP79dQZToH1Fsc9w130_provenance.
- NP1163053.RAQw6eCkcym3-fVT_5mIryZC-ixjoBP79dQZToH1Fsc9w130_assertion wasGeneratedBy ECO_0000203 NP1163053.RAQw6eCkcym3-fVT_5mIryZC-ixjoBP79dQZToH1Fsc9w130_provenance.